慢性病数字疗法的医疗保险政策探讨  

Discussion on medical insurance policy of digital therapy for chronic disease

作　　者：杨雪晴 刘杨 王亚强 陈东[2] 吴昊天 胡一鸣 周倩 吴静[1] YANG Xueqing;LIU Yang;WANG Yaqiang;CHEN Dong;WU Haotian;HU Yiming;ZHOU Qian;WU Jing(National Center for Chronic and Non-communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 100050,China;The Seventh Affiliated Hospital,Southern Medical University)

机构地区：[1]中国疾病预防控制中心慢性非传染性疾病预防控制中心,北京100050 [2]南方医科大学第七附属医院

出　　处：《中国数字医学》2025年第4期97-101,共5页China Digital Medicine

基　　金：中国工程院2022年重大战略研究与咨询项目——全民健康管理工程研究(2022-XBZD-21-02);广东省基础与应用基础研究基金项目-基于毫米波雷达的无扰式智能生命体征检测方法研究(2022A1515140109);广州市卫生健康科技项目-基于医防融合和慢病多病一体化融合管理理念的广州市慢性病管理创新模式(2024A031007)。

摘　　要：医疗保险在慢性病管理中发挥着重要的杠杆作用,通过梳理总结我国慢性病管理应用数字化技术的相关政策,探讨国内外数字疗法在慢性病领域的应用情况及其医保支付政策,最后提出慢性病数字疗法的医疗保险发展建议,期望能为我国慢性病管理的数字化发展提供完善保障。Medical insurance plays an important role in chronic disease management.By sorting out and summarizing the relevant policies on the application of digital technology in chronic disease management in China,discussing the application of digital therapy in the field of chronic disease at home and abroad,and its medical insurance payment policy,medical insurance development suggestions for chronic disease digital therapy are proposed,aiming to provide perfect support for the digital development of chronic disease management in China.

关 键 词：慢性病 数字疗法 医疗保险 

分 类 号：R197.3[医药卫生—卫生事业管理] R319[医药卫生—公共卫生与预防医学]